RxDoctor Payments Data

Bonnie Brown, NP

Family · Gainesville, GANPI 1669191334

Payments from drug & device makers

$1,423in general payments, 2019–2025

Across 71 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$394
  • Novartis$292
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$195
  • Pfizer$113
  • Boehringer Ingelheim$104
  • AstraZeneca$66
  • plus $259 from 6 others

What the payments were for

  • Food & beverage$1,423100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,423 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$32,245
Medicare patients
222
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol124$109,488
Repatha SureclickEvolocumab104$86,561
EliquisApixaban44$62,973
BrilintaTicagrelor53$48,480
EntrestoSacubitril/Valsartan27$46,536
Praluent PenAlirocumab22$17,343
VascepaIcosapent Ethyl23$14,763
JardianceEmpagliflozin11$8,671
Ranolazine ErRanolazine51$5,061
Ezetimibe201$3,912
Icosapent Ethyl11$3,453
ClopidogrelClopidogrel Bisulfate237$2,405
Metoprolol Succinate172$2,361
Atorvastatin Calcium288$2,169
Rosuvastatin Calcium126$1,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$66$157,969177 claims
PfizerEliquis$113$62,97344 claims
NovartisEntresto$292$46,53627 claims
Boehringer IngelheimJardiance$104$8,67111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →